About Akron Biotech

About Akron Biotech > Team

Specialist teams work together to deliver the highest quality products and services to the industry.

Akron's Team

Akron’s experienced teams offer comprehensive services and support for all stages of the product lifecycle. Our teams combine biotechnology-specialized project management and outstanding up-to-date technical knowledge and business acumen. Under the expert advice and guidance of the Scientific Advisory Board, Dr. Claudia Zylberberg, Founder and CEO, leads teams in the development and execution of Akron’s commercial strategy. 

Claudia Zylberberg, PhD; Founder and CEO

Dr. Zylberberg has more than 25 years’ experience in the biomedical research and biotechnology industries, and first-hand knowledge of what it takes to bring products through R&D, and on to approval and commercialization. She is highly knowledgeable about current FDA regulations, qualification of raw materials, process design and validation, and bioassay development.

Dr. Zylberberg is proud to act as advisor and consultant to organizations worldwide regarding the regulatory roadmap and commercialization of cell therapies and stem cell banking. In addition, she brings her expertise in recombinant proteins, media development, combinational (devices), and platform technologies to Akron. She is the inventor of numerous patented proprietary technologies, and has an extensive peer-reviewed publication record. 

Dr. Zylberberg is affiliated with the International Society for Cell Therapy (ISCT) and holds many nonexecutive positions: Board Member and Scientific Advisor, Alliance for Regenerative Medicine (ARM);  Board Member, BioFlorida;  Board Member, Banner Center of Life Sciences, Palm Beach  State College; and Chair of Industry Advisory Board, West Palm Beach, Florida.